UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+year period

Durao-Carvalho, Goncalo; Fernandez-Gonzalez, Raquel; Goulden, Bethan; Farinha, Filipa; Isenberg, David; (2023) Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+year period. Rheumatology , 62 (1) pp. 209-216. 10.1093/rheumatology/keac242. Green open access

[thumbnail of Isenberg_Major determinants of prolonged remission in systemic lupus erythematosus_AAM.pdf]
Preview
Text
Isenberg_Major determinants of prolonged remission in systemic lupus erythematosus_AAM.pdf

Download (873kB) | Preview

Abstract

OBJECTIVES: To investigate predictors of sustained complete remission (CR) for 3 and 5 years, minimum. METHODS: Retrospective observational study from January 1978-december 2019, including Systemic Lupus Erythematosus (SLE) patients who attended the Lupus Clinic in a tertiary hospital, for at least 3 years. We used the British Isles Lupus Assessment Group (BILAG) score and serological profile to classify patients into CR, serologically active clinically quiescent (SACQ) and serological remission (SR). Multivariable cox regression analysis was performed to investigate predictors of CR and Kaplan-Meier curves were obtained. RESULTS: We included 564 patients; 15% achieved CR, 7% SACQ, 15% SR. 63% attained no remission. In the CR group, 73% sustained the remission for 5 or more years. Patients who did not reach any kind of sustained remission died significantly earlier (p< 0.001). Cumulative survival figures at 5, 10, 20 and 30 years were 100, 100, 94 and 90%, respectively, for CR patients and 96, 93, 77 and 58%, respectively, for patients in the no-remission group. Significant predictors of CR were white ethnicity, adjusted hazard ratio (HR) 2.16 [95% ci 1.30-3.59] p= 0.003; older age at diagnosis (>32-years), HR 1.92 [1.24-2.97] p= 0.003; absence of renal involvement, HR 2.55 [1.39-4.67] p= 0.002; and of antiphospholipid syndrome (APS), HR 4.92 [1.55-15.59] p= 0.007. CONCLUSION: Patients not achieving any kind of sustained remission have a higher risk of early mortality. White ethnicity, older age at diagnosis, absence of renal involvement and of APS were significantly associated with CR. Predictors for sustained CR do not change whether a 3-year or 5-year period is applied.

Type: Article
Title: Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+year period
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/rheumatology/keac242
Publisher version: https://doi.org/10.1093/rheumatology/keac242
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: SLE, prolonged complete remission, off therapy, mortality
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
URI: https://discovery.ucl.ac.uk/id/eprint/10152536
Downloads since deposit
99Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item